Skip to main content
Premium Trial:

Request an Annual Quote

Waters Buys Sweden's Thermometrics for $2.5M, Will Merge With TA Instruments Unit

NEW YORK (GenomeWeb News) – Waters said today it has acquired privately held Thermometric, a maker of high-performance microcalorimeters, for around $2.5 million.
 
Waters plans to merge the Jarfalla, Sweden-based company into its TA Instruments unit, which is located in New Castle, Del.
 
Thermometric generates around $4 million in annual sales. Waters said it expects the purchase to be neutral to its 2006 earnings.
 
The company’s flagship product, the TAM III, is a modular calorimeter “routinely used to characterize materials, and their interactions, in the fields of pharmaceuticals, life and materials sciences.”
 
TA Instruments President Terry Kelly said Thermometric’s products and technologies complement its “position in thermal analysis and will allow us to expand our business into new applications, especially in life science research.”
 
Waters acquired TA in 1996. The company said thermometrics complements liquid chromatography, mass spectrometry, and thermal analysis, three markets in which Waters competes.
 
According to Thermometric’s website, the TAM can be used to study many phenomena associated with metabolic activity, including applications in cancer research where the technology can be used as bioassays to detect disorders of cellular metabolism.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.